Blog
RSS FeedPosted by Michael Wonder on 09 Apr 2022
PBS listing of Paxlovid (nirmatrelvir and ritonavir)
9 April 2022 - Commencing 1 May 2022, Paxlovid (nirmatrelvir and ritonavir) will be listed on the PBS as a General ...
Posted by Michael Wonder on 09 Apr 2022
Life Saving Drugs Program – medicines reviews recommendations
7 April 2022 - This document outlines 51 recommendations from the Life Saving Drugs Expert Panel review. ...
Posted by Michael Wonder on 09 Apr 2022
PBAC recommendation for nirmatrelvir and ritonavir (Paxlovid) - March 2022
9 April 2022 - The PBAC undertook an expedited consideration of a submission to add the combination product, nirmatrelvir and ritonavir ...
Posted by Michael Wonder on 05 Apr 2022
Consultation now open - review of base case discount rate at 3A.1 of the PBAC Guidelines
5 April 2022 - The Commonwealth has entered into a new Strategic Agreement in relation to reimbursement, health technology assessment ...
Posted by Michael Wonder on 04 Apr 2022
Mystery solved over Hansard change to hide budget’s missing $10 drug price cut
4 April 2022 - Financial Services Minister Jane Hume’s office asked Hansard staff to delete references to a planned $10 ...
Posted by Michael Wonder on 01 Apr 2022
Price slashed for revolutionary $78,000 a year prostate cancer treatment Lynparza
1 April 2022 - A new subsidy for a revolutionary drug is set to benefit thousands of Aussie men with aggressive ...
Posted by Michael Wonder on 01 Apr 2022
Making medicines more affordable for more Australians
1 April 2022 - Australians will have cheaper access to treatments for high cholesterol, heart failure and high blood pressure from ...
Posted by Michael Wonder on 01 Apr 2022
Public Summary Documents – December 2021 PBAC meeting
1 April 2022 - The Public Summary Documents (positive recommendations and subsequent decisions not to recommend) from the December 2021 PBAC ...
Posted by Michael Wonder on 31 Mar 2022
Agenda for July 2022 PBAC meeting
1 April 2022 - 30 March 2022 - The agenda for the July 2022 PBAC meeting is now available. ...
Posted by Michael Wonder on 31 Mar 2022
Schedule of Pharmaceutical Benefits - 1 April 2022
1 April 2022 - The April 2022 issue of the Schedule of Pharmaceutical Benefits is out and now in effect. ...
Posted by Michael Wonder on 31 Mar 2022
2022 April cycle - brand price reductions and savings to patients
31 March 2022 - Brand price reductions and savings to patients resulting from the 2022 April cycle of price disclosure have ...
Posted by Michael Wonder on 30 Mar 2022
Government hopes to hook voters with cheaper drugs
29 March 2022 - Patients will get access to cheaper or free medicines sooner under plans to reduce the PBS ...
Posted by Michael Wonder on 29 Mar 2022
Federal budget 2022: more funding for breast cancer drug Trodelvy
29 March 2022 - Against all the odds Sydney mum Alison Day will get to celebrate her daughter’s 12th birthday — ...
Posted by Michael Wonder on 29 Mar 2022
Government fails to adequately address medicine affordability for working Australians
29 March 2022 - The cost of medicines will continue to go up unchecked as the Federal Government has failed ...
Posted by Michael Wonder on 29 Mar 2022
Budget 2022-23 – no ‘big bang’ announcements in health
29 March 2022 - Medicines Australia welcomes tonight’s Budget announcements for new PBS listings and on-going COVID-19 measures. ...